Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
45,466,239
-
Share change
-
+255,056
-
Total reported value
-
$566,540,993
-
Put/Call ratio
-
52%
-
Price per share
-
$12.46
-
Number of holders
-
76
-
Value change
-
+$4,511,593
-
Number of buys
-
40
-
Number of sells
-
36
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q1 2019
As of 31 Mar 2019,
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,466,239 shares.
The largest 10 holders included
NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, OppenheimerFunds, Inc., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Redmile Group, LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, and JENNISON ASSOCIATES LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.